Outlook Therapeutics, Inc.
OTLK- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001649989
In the last 90 days, Outlook Therapeutics, Inc. insiders filed 4 open-market purchases and 0 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $32.2M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Outlook Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 63 | 63 | 0 |
| Shares | 20.2M | 21.2M | +922.1K (+4.6%) |
| Value | $50.4M | $46.0M | −$4.41M (−8.8%) |
New holders (8)
Institutions that held Outlook Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 960,259 | $2.08M | 0.00% |
| Renaissance Technologies LLC | 254,781 | $553.0K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 111,100 | $241.0K | 0.00% |
| SG Americas Securities, LLC | 44,828 | $97.0K | 0.00% |
| Commonwealth Equity Services, LLC | 21,522 | $46.0K | 0.00% |
| Infrastructure Capital Advisors, LLC | 17,300 | $38.0K | 0.01% |
| Walleye Trading LLC | 15,071 | $33.0K | 0.00% |
| Endurance Wealth Management, Inc. | 15,000 | $33.0K | 0.00% |
Sold out (8)
Institutions that held Outlook Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Jane Street Group, LLC | 63,967 | $160.0K |
| D. E. Shaw & Co., Inc. | 30,135 | $75.0K |
| Alliancebernstein L.P. | 17,000 | $42.0K |
| Virtu Financial LLC | 14,146 | $35.0K |
| XTX Topco Ltd | 10,871 | $27.0K |
| TrinityPoint Wealth, LLC | 10,000 | $25.0K |
| Advisory Services Network, LLC | 6,055 | $15.0K |
| UBS Group AG | 5,072 | $13.0K |